论文部分内容阅读
德国马普学会已开始对位于海德堡的马普学会医学研究所所长皮特·西伯格是否存在科学上的不良行为展开调查。此前,西伯格曾在法庭上称,他与来自美国基因技术公司(Genentech)的同事于1979年在英国《自然》杂志上发表的一篇论文数据表述有误。这次调查是由马普学会生物处副主任克劳斯·霍尔布鲁克发起的,起因是,西伯格向《自然》和《科学》杂志写信称,他们的论文中有关克隆人类生长激素基因的实施表述有误。这将是马普学会关于处理科学上的不良行为的新条例于一年多以前颁布以来所进行的第一次调查。调查委员会由德国联
The German Max Planck Institute has started investigating whether Pitt Sieber, director of the Max Planck Institute for Medical Research in Heidelberg, has any scientific misconduct. Seibel had previously said in court that his paper with a colleague from Genentech in the 1979 issue of Nature in the United Kingdom had incorrectly stated the data. The investigation was initiated by Klaus Holbrook, deputy director of the Max Planck Institute for Biological Sciences, because Seibel wrote letters to Nature and Science that their paper was about cloning human growth hormone The implementation of the gene is incorrect. This will be the first survey conducted by the Maple Association since the enactment of the new ordinance on dealing with scientific misconduct more than a year ago. Commission of inquiry by Germany